Anti-CELF5 antibody (STJA0009671)

SKU:
STJA0009671

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-CUGBP Elav-like family member 5 is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CELF5
Gene ID: 60680
Uniprot ID: CELF5_HUMAN
Specificity: This antibody detects endogenous levels of BRUNOL5 at Human
Immunogen: Synthesized peptide derived from human BRUNOL5
Function RNA-binding protein implicated in the regulation of pre-mRNA alternative splicing. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of cardiac isoforms of TNNT2 during heart remodeling at the juvenile to adult transition. Binds to muscle-specific splicing enhancer (MSE) intronic sites flanking the alternative exon 5 of TNNT2 pre-mRNA.
Protein Name Cugbp Elav-Like Family Member 5
Celf-5
Bruno-Like Protein 5
Cug-Bp- And Etr-3-Like Factor 5
Rna-Binding Protein Brunol-5
Cellular Localisation Nucleus
Cytoplasm
Alternative Antibody Names Anti-Cugbp Elav-Like Family Member 5 antibody
Anti-Celf-5 antibody
Anti-Bruno-Like Protein 5 antibody
Anti-Cug-Bp- And Etr-3-Like Factor 5 antibody
Anti-Rna-Binding Protein Brunol-5 antibody
Anti-CELF5 antibody
Anti-BRUNOL5 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance